Montelukast Prescribing at PROSPECT MEDICAL PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
887
Total Quantity
25.5K
NHS Cost
£1.3K
vs National Avg
+29.5%
PROSPECT MEDICAL PRACTICE prescribed 887 items of Montelukast over the last 12 months at a cost of £1,294 to the NHS. This is 29.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
75
Jul 2026
80
Jul 2026
77
Jul 2026
83
Jul 2026
80
Jul 2026
71
Jul 2026
71
Jul 2026
73
Jul 2026
72
Jul 2026
69
Jul 2026
68
Jul 2026
68
Prescribing Details
| Total Items | 887 |
|---|---|
| Total Quantity | 25,501 |
| Total NHS Cost | £1,294 |
| Presentations | 4 different forms |
| vs National Average | +29.5% |
Montelukast Prescribing Comparison
| This practice | 887 items |
|---|---|
| National average per practice | 685 items |
| Difference | +29.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.